The new Republican Congress is naturally antipathetic to the US Food and Drug Administration, but radical change will not be easily accomplished, which is just as well.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
End of the line in sight for PDA?. Nature 376, 713–714 (1995). https://doi.org/10.1038/376713a0
Issue Date:
DOI: https://doi.org/10.1038/376713a0